Cite Filings / RYTM / 0001415889-25-022024

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

RHYTHM PHARMACEUTICALS, INC. Filed 2025-08-14 Acc 0001415889-25-022024

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-10-30 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-14 4 Chief Financial Officer sold 28,088 shares at an average $96.29 ($2,704,624)
2025-08-14 4 Corporate Controller & CAO sold 1,500 shares at $95.00 ($142,500)
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-13 4 Chief Technical Officer sold 3,984 shares at $90.08 ($358,891)
2025-08-12 144 Sale of Securities

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…